To request prior authorization for a GLP-1 medication, you and your healthcare provider must work together to submit a formal request to your insurance company
Results At baseline, no significant difference in age, gender, etiology, branched-chain amino acid administration, and serum total carnitine level between the two groups (Table 1)
Hamel, KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs, Poll Finding (2024)
Demyelination causes a multitude of neurological symptoms, including loss of coordination of movement, ataxia, visual impairments, psychiatric abnormalities such as depression, and cognitive decline (Preiningerova et al., 2022)
Non-clinical only: Not intended for diagnostic, therapeutic, or clinical use
Patients should not assume that BPC-157 or TB-500 are FDA-approved treatments for injury recovery